Log in to save to my catalogue

Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlat...

Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_373964

Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlation with Lung Function and Inflammation

About this item

Full title

Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlation with Lung Function and Inflammation

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Cellular Physiology and Biochemistry, 2015-01, Vol.35 (4), p.1437-1453

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background: Liver impairment, ranging from steatosis to cirrhosis, is frequent in cystic fibrosis (CF) patients and is becoming increasingly significant due to their improved life expectancy. One aspect of hepatic alterations is caused by increased fecal loss of the essential nutrient choline, following enterohepatic bile phosphatidylcholine (PC) c...

Alternative Titles

Full title

Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlation with Lung Function and Inflammation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_karger_primary_373964

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_373964

Other Identifiers

ISSN

1015-8987

E-ISSN

1421-9778

DOI

10.1159/000373964

How to access this item